Literature DB >> 10052957

Induced fit activation mechanism of the exceptionally specific serine protease, complement factor D.

F R Taylor1, S A Bixler, J I Budman, D Wen, M Karpusas, S T Ryan, G J Jaworski, A Safari-Fard, S Pollard, A Whitty.   

Abstract

We have investigated the mechanism by which the complement protease, Factor D, achieves its high specificity for the cleavage of Factor B in complex with C3(H2O). Kinetic experiments showed that Factor B and C3(H2O) associate with a KD of >/=2.5 microM and that Factor D acts on this complex with a second-order rate constant of kcat/KM >/= 2 x 10(6) M-1 s-1, close to the rate of a diffusion-controlled reaction for proteins of this size. In contrast, Factor D, which is a member of the trypsin family of serine proteases, was 10(3)-10(4)-fold less active than trypsin toward both thioester and p-nitroanilide substrates containing an arginine at P1. Furthermore, peptides spanning the Factor B cleavage site were not detectably cleaved by Factor D (kcat/KM </= 0.5 M-1 s-1). These results imply that contacts between Factor D and the C3(H2O)B complex, outside the vicinity of the cleavage site in Factor B, generate >/=9 kcal/mol of binding energy to stabilize the transition state for reaction. In support of this, we demonstrate that chemical modification of Factor D at a single lysine residue that is distant from the active site abolishes the activity of the enzyme toward Factor B while not affecting activity toward small synthetic substrates. We propose that Factor D may exemplify a special case of the induced fit mechanism in which the requirement for conformational activation of the enzyme results in a substantial increase in substrate specificity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10052957     DOI: 10.1021/bi982140f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.

Authors:  S R Barnum
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

2.  Access to the complement factor B scissile bond is facilitated by association of factor B with C3b protein.

Authors:  Dennis E Hourcade; Lynne M Mitchell
Journal:  J Biol Chem       Date:  2011-08-23       Impact factor: 5.157

3.  Structure Determination of Mycobacterium tuberculosis Serine Protease Hip1 (Rv2224c).

Authors:  Jacqueline L Naffin-Olivos; Andrew Daab; Andre White; Nathan E Goldfarb; Amy C Milne; Dali Liu; Jacqueline Baikovitz; Ben M Dunn; Jyothi Rengarajan; Gregory A Petsko; Dagmar Ringe
Journal:  Biochemistry       Date:  2017-04-07       Impact factor: 3.162

4.  Structures of C3b in complex with factors B and D give insight into complement convertase formation.

Authors:  Federico Forneris; Daniel Ricklin; Jin Wu; Apostolia Tzekou; Rachel S Wallace; John D Lambris; Piet Gros
Journal:  Science       Date:  2010-12-24       Impact factor: 47.728

Review 5.  Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases.

Authors:  József Dobó; Andrea Kocsis; Péter Gál
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

6.  Ensemble refinement shows conformational flexibility in crystal structures of human complement factor D.

Authors:  Federico Forneris; B Tom Burnley; Piet Gros
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-15

7.  C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.

Authors:  M M Ruseva; M Takahashi; T Fujita; M C Pickering
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

Review 8.  Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway.

Authors:  Jonathan Barratt; Ilene Weitz
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.